Appointed
Alan Grujic
Director
GTHP ·
GUIDED THERAPEUTICS INC
the Board appointed Mr. Alan Grujic to replace Mr. Cartwright on the Board, effective March 8, 2023.
Ready 8-Ks
10
Latest filing
March 10, 2026, 7:59 PM ET
Top materiality
0.85
Event mix
other_material ×8 · leadership ×1 · other ×1
Sentiment
2 pos · 0 neg · 8 neu
Executive change
recent →
Recent 8-K filings for GTHP
Highest-materiality recent filing
Guided Therapeutics closes $3.3M bridge financing, exchanges Auctus debt, targets FDA study completion
- Raised ~$3.3M via 6.6M shares at $0.50 each, plus four-year warrants for 6.6M shares at $0.50 and 6.6M at $0.65.
- Auctus exchanged $1.06M debt and 8.78M warrants for $1.95M in units (3.9M shares, 3.9M warrants at $0.50 and $0.65); residual $490K debt over 18 months.
-
Raised ~$3.3M via 6.6M shares at $0.50 each, plus four-year warrants for 6.6M shares at $0.50 and 6.6M at $0.65.
-
Guided Therapeutics passes regulatory review in China; receives $133K payment from SMI
Clinical trial at Fudan University approved; trials at 4 centers start Q3 2021.
Executive changes
Departed
Gene Cartwright
President and Chief Executive Officer
GTHP ·
GUIDED THERAPEUTICS INC
Dr. Gene Cartwright notified the Board of Directors (the “ Board ”) of Guided Therapeutics, Inc. (the “ Company ”) of his intent to retire from his position as President and Chief Executive Officer of the Company and as a member of the Board, effective immediately.
Appointed
Mark Faupel
President and Chief Executive Officer
GTHP ·
GUIDED THERAPEUTICS INC
the Board appointed Dr. Mark Faupel, Ph.D., 67, the Company’s Chief Operating Officer since December 2016, to replace Mr. Cartwright as the Company’s President and Chief Executive Officer, effective as of March 6, 2023.
Materiality & sentiment trend
Max materiality 0.85 · Median 0.50 · Most common event other_material